04/22/2024
4:06 PM | Soleno Therapeutics (Filer)
| Form ARS | |
04/22/2024
3:31 PM | Soleno Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024
3:15 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2024
8:36 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
8:37 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
8:39 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
8:40 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/07/2024
5:06 AM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
4:35 PM | JANUS HENDERSON GROUP PLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G/A | |
02/07/2024
7:01 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G/A | |
01/30/2024
3:57 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
4:42 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:44 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:47 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:31 PM | MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:34 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:35 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:36 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:37 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:16 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
5:00 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
6:57 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
4:09 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
8:32 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
8:32 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
8:34 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
8:34 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
3:46 PM | Soleno Therapeutics (Subject)
Yen Kristen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
3:53 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
5:17 PM | Soleno Therapeutics (Subject)
Yen Kristen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023
6:05 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023
6:21 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023
7:41 PM | MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
7:02 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
7:03 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
7:04 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
7:06 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:50 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:51 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:52 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:52 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Protect Yourself While There’s Still Time … (Ad) The next step of the Fed's control is here.
Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week.
Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. |
10/31/2023
11:15 PM | Soleno Therapeutics (Filer)
| Form EFFECT | |
10/23/2023
3:20 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
10/20/2023
3:32 PM | Soleno Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/16/2023
3:30 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
10/12/2023
3:30 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
10/12/2023
3:05 PM | COMMODORE CAPITAL LP (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
10/11/2023
3:30 PM | Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13D/A | |
10/10/2023
3:30 PM | Fairmount Funds Management LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
10/06/2023
10:45 AM | JANUS HENDERSON GROUP PLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
10/05/2023
4:09 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
10/04/2023
3:30 PM | Soleno Therapeutics (Issuer)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2023
9:36 AM | Soleno Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
10/02/2023
6:54 PM | Abingworth Bioventures VII LP (Reporting)
Abingworth LLP (Reporting)
Carlyle Genesis UK LLC (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
Carlyle Investment Management LLC (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
Soleno Therapeutics (Issuer)
TC Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/29/2023
3:51 PM | Soleno Therapeutics (Filer)
| Form 424B5 | |
09/28/2023
8:51 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
09/28/2023
4:00 PM | Soleno Therapeutics (Issuer)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/28/2023
2:45 PM | EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/28/2023
6:00 AM | Soleno Therapeutics (Subject)
| Form FWP | |
09/28/2023
6:02 AM | Soleno Therapeutics (Subject)
| Form FWP | |
09/27/2023
8:32 PM | Soleno Therapeutics (Filer)
| Form S-3MEF | |
09/27/2023
4:23 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2023
4:26 PM | Soleno Therapeutics (Filer)
| Form 424B5 | |
09/26/2023
6:30 AM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/18/2023
3:15 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
08/16/2023
3:12 PM | Pauls Matthew (Reporting)
Soleno Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/16/2023
3:13 PM | Pauls Matthew (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
8:00 AM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
4:25 PM | Soleno Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/02/2023
11:15 PM | Soleno Therapeutics (Filer)
| Form EFFECT | |
07/21/2023
3:10 PM | Soleno Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
07/10/2023
3:06 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2023
7:13 PM | Soleno Therapeutics (Issuer)
Volck Birgitte (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
4:41 PM | EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
4:00 PM | Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13D | |
05/30/2023
3:15 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
05/26/2023
5:26 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
5:27 PM | Harris William G (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
5:28 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
5:28 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
5:29 PM | MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
5:30 PM | Melincoff Gwen A (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
5:30 PM | Sinclair Andrew (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
5:39 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
4:57 PM | EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
12:14 PM | SCHULER JACK W (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
05/23/2023
5:47 PM | EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2023
3:31 PM | EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Soleno Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/18/2023
3:32 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D | |
05/15/2023
3:04 PM | SCHULER JACK W (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
4:28 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Protect Yourself While There’s Still Time … (Ad) The next step of the Fed's control is here.
Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week.
Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. |
05/10/2023
4:28 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
3:30 PM | Abingworth LLP (Reporting)
Carlyle Genesis UK LLC (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
Carlyle Investment Management LLC (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
Soleno Therapeutics (Issuer)
TC Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
3:32 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
05/09/2023
3:31 PM | Soleno Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/03/2023
4:26 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
